Experimental
Alzheimer's drug shows promise against brain plaques
An experimental drug called aducanumab
dramatically reduced the toxic plaques found in the brains of people living
with Alzheimer's disease, according to results of a Phase1b clinical trial
designed to test safety and tolerability rather than effectiveness. The
results, previously reported at the Alzheimer’s Association International
Conference® 2015 (AAIC®), hinted that the drug may also be able to slow the
loss of memory and thinking. Experts caution that additional, larger
studies will be necessary to determine if aducanumab has an effect on
slowing down Alzheimer’s. Read More
|
|
Repetitive
behavior may be stressful for Alzheimer’s caregivers
|
|
A person with Alzheimer's may do or say
something over and over — like repeating a word, question or activity —
or undo something that has just been finished. Repetition can be
stressful for the caregiver, but remember that it’s the disease causing
the behavior, not the person. Read More
|
|
|
|
|
|
Alzheimer's disease
may have an effect on your relationships
|
|
While your abilities may change over time with
Alzheimer’s, how you continue to be a partner in your relationships can
impact your ability to live well with the disease. Establishing and
maintaining meaningful relationships throughout your Alzheimer's experience
can enhance your ability to stay both physically and emotionally healthy. Read More
|
|
|
|
